scispace - formally typeset
M

Malcolm J. Kavarana

Researcher at GlaxoSmithKline

Publications -  18
Citations -  688

Malcolm J. Kavarana is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: In vivo & Sphingosine-1-phosphate. The author has an hindex of 7, co-authored 18 publications receiving 584 citations.

Papers
More filters
Patent

Methods for synthesis of encoded libraries

TL;DR: In this article, a method of synthesizing libraries of molecules which include an encoding oligonucleotide tag was proposed. But this method is not suitable for the use of binary codes.
Patent

Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity

TL;DR: In this article, the authors present compounds which modulate the activity of the SI P1 receptor, and the use of these compounds for treating conditions associated with signaling through the S 1 P 1 receptor.
Patent

Methods for identifying compounds of interest using encoded libraries

TL;DR: In this article, a method for identifying a compound of interest by screening libraries of molecules which include an encoding oligonucleotide tag was proposed, which was used to identify a compound.
Journal ArticleDOI

Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonists.

TL;DR: In the design of potent and selective sphingosine-1-phosphate receptor agonists, two series of molecules based on phenylamide and phenylimidazole analogs of FTY-720 demonstrated dose responsive lymphopenia, when administered orally.